Details for Patent: 8,492,416

Summary for Patent: 8,492,416

Title:	2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
Abstract:	The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, ##STR00001## wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
Inventor(s):	Kenda; Beno t (Emines, BE), Pasau; Patrick (Chastre, BE), Lallemand; Benedicte (Namur, BE)
Assignee:	UCB Pharma, S.A. (Brussels, BE)
Application Number:	13/222,477
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,492,416
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 8,492,416

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 8,492,416

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0004297.8	Feb 23, 2000

International Family Members for US Patent 8,492,416

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1265862		PA2016013	Lithuania
European Patent Office	1452524		300815	Netherlands
European Patent Office	1452524		CA 2016 00013	Denmark
European Patent Office	1452524		16C1001	France